Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

Introduction<p>T cell receptor-engineered T cell therapy has emerged as a promising approach in cancer immunotherapy, leveraging the ability of T cells to recognize tumor antigens presented on major histocompatibility complex molecules, offering a targeted approach for treating cancers. This s...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Saleh Alrhmoun (19193851) (author)
Otros Autores:	Roman Perik-Zavodskii (19193839) (author), Marina Fisher (19828437) (author), Julia Lopatnikova (4164058) (author), Olga Perik-Zavodskaia (19193842) (author), Julia Shevchenko (19193845) (author), Kirill Nazarov (19193854) (author), Julia Philippova (19828440) (author), Vasily Kurilin (19828443) (author), Olga Kichakova (22680860) (author), Evgenii Zavjalov (12230774) (author), Elena Golikova (472121) (author), Petr Timashev (10031740) (author), Petr Glybochko (13011754) (author), Sergey Sennikov (4164055) (author)
Publicado:	2025
Materias:	Genetic Immunology TCR-T cells TCR-T T cells adoptive cell therapy her2/neu ErbB2 ScRNA-seq
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Data Sheet 1_Anti-HER2/neu TCR-T Cells in Action: linking transcriptional signatures, secretomics, and In Vivo tumor suppression.docx

Ejemplares similares